Psoriatic arthritis: treatment strategies using biologic agents
Submitted: 30 April 2012
Accepted: 5 June 2012
Published: 5 June 2012
Accepted: 5 June 2012
Abstract Views: 1108
PDF: 1133
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- G. Filippou, B. Frediani, The diagnosis of calcium pyrophosphate dihydrate crystal deposition disease: the good, the bad and… ultrasonography! , Reumatismo: Vol. 64 No. 3 (2012)
- P. Pinto-Lopes, L. Carneiro-Leão, R. Morais, J. Pinheiro, A. Vieira Lopes, P. Bettencourt, Acute heart failure and rhabdomyolysis: a clue for the diagnosis of polymyositis with cardiac involvement , Reumatismo: Vol. 69 No. 2 (2017)
- B. Isci, T.S. Gamsiz, S. Kayipmaz, O. Keskin, M.E. Tezcan, Pulmonary cavitary lesions may be one of the presenting features in Ig A nephropathy , Reumatismo: Vol. 70 No. 2 (2018)
- C. Gioia, A. Picchianti Diamanti, R. Perricone, M.S. Chimenti, A. Afeltra, L. Navarini, A. Migliore, U. Massafra, V. Bruzzese, P. Scolieri, C. Meschini, M. Paroli, R. Caccavale, P. Scapato, R. Scrivo, F. Conti, B. Laganà, M. Di Franco, Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies , Reumatismo: Vol. 75 No. 4 (2023)
- M. Cutolo, IL-1Ra: its role in rheumatoid arthritis , Reumatismo: Vol. 56 No. s1 (2004)
- F. Ingegnoli, N. Del Papa, E. Lupi, D.P. Comina, W. Maglione, V. Gerloni, F. Fantini, Anti-chromatin antibodies in juvenile rheumatoid arthritis , Reumatismo: Vol. 55 No. 4 (2003)
- Giuseppe D'Alessandro, Maria Rosaria Bianco, Spiridon Politis, Celestino Ferrandina, Giuseppe Rossi, Emanuele Altomare, Case report: AREB in a patient with rheumatoid arthritis treated with methotrexate and infliximab , Reumatismo: Vol. 58 No. 1 (2006)
- G. Ferraccioli, Biologic therapy with anti-TNFa in rheumathoid atrhritis , Reumatismo: Vol. 57 No. s4 (2005)
- E. Lubrano, A. Armuzzi, S. Scriffignano, C. Felice, F.M. Perrotta, V. Venerito, S. Del Vescovo, R. Ramonda, G. Cassone, F. Atzeni, R. Caporali, F. Conti, E. Gremese, F. Iannone, M. Sebastiani, E.G. Favalli, The holistic management of peripheral spondyloarthritis: focus on articular involvement in patients with inflammatory bowel disease , Reumatismo: Early Access
- B. Raffeiner, C. Botsios, F. Ometto, L. Bernardi, A. Montante, P. Sfriso, S. Todesco, L. Punzi, TNFα blockers and infectious risk in rheumatoid arthritis , Reumatismo: Vol. 61 No. 3 (2009)
<< < 16 17 18 19 20 21 22 23 24 25 > >>
You may also start an advanced similarity search for this article.